Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.

Demonbreun AR, Allen MV, Warner JL, Barefield DY, Krishnan S, Swanson KE, Earley JU, McNally EM.

Am J Pathol. 2016 Jun;186(6):1610-22. doi: 10.1016/j.ajpath.2016.02.005. Epub 2016 Apr 9.

PMID:
27070822
2.

Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Blazek AD, Paleo BJ, Weisleder N.

Physiology (Bethesda). 2015 Nov;30(6):438-48. doi: 10.1152/physiol.00019.2015. Review.

PMID:
26525343
3.

CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.

Yin X, Wang Q, Chen T, Niu J, Ban R, Liu J, Mao Y, Pu C.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3069-75. eCollection 2015.

4.

Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.

Roche JA, Tulapurkar ME, Mueller AL, van Rooijen N, Hasday JD, Lovering RM, Bloch RJ.

Am J Pathol. 2015 Jun;185(6):1686-98. doi: 10.1016/j.ajpath.2015.02.020. Epub 2015 Apr 25.

5.

Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.

Lee MS, Jones T, Song DY, Jang JH, Jung JU, Gao SJ.

PLoS Pathog. 2014 Sep 25;10(9):e1004412. doi: 10.1371/journal.ppat.1004412. eCollection 2014 Sep.

6.

FER-1/Dysferlin promotes cholinergic signaling at the neuromuscular junction in C. elegans and mice.

Krajacic P, Pistilli EE, Tanis JE, Khurana TS, Lamitina ST.

Biol Open. 2013 Oct 15;2(11):1245-52. doi: 10.1242/bio.20135637. eCollection 2013.

7.

Dysferlin and animal models for dysferlinopathy.

Kobayashi K, Izawa T, Kuwamura M, Yamate J.

J Toxicol Pathol. 2012 Jun;25(2):135-47. doi: 10.1293/tox.25.135.

8.

Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.

Lostal W, Bartoli M, Roudaut C, Bourg N, Krahn M, Pryadkina M, Borel P, Suel L, Roche JA, Stockholm D, Bloch RJ, Levy N, Bashir R, Richard I.

PLoS One. 2012;7(5):e38036. doi: 10.1371/journal.pone.0038036. Epub 2012 May 29.

9.

Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice.

Kobayashi K, Izawa T, Kuwamura M, Yamate J.

J Toxicol Pathol. 2011 Mar;24(1):49-62. doi: 10.1293/tox.24.49. Epub 2011 Mar 31.

10.

Muscle membrane repair and inflammatory attack in dysferlinopathy.

Han R.

Skelet Muscle. 2011 Mar 1;1(1):10. doi: 10.1186/2044-5040-1-10.

11.

Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.

Díaz-Manera J, Touvier T, Dellavalle A, Tonlorenzi R, Tedesco FS, Messina G, Meregalli M, Navarro C, Perani L, Bonfanti C, Illa I, Torrente Y, Cossu G.

Cell Death Dis. 2010 Aug 5;1:e61. doi: 10.1038/cddis.2010.35.

12.

Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.

Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, Moore SA, Ng R, Beltrán-Valero de Bernabé D, Faulkner JA, Campbell KP.

J Clin Invest. 2010 Dec;120(12):4366-74. doi: 10.1172/JCI42390. Epub 2010 Nov 8.

13.

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Lerario A, Cogiamanian F, Marchesi C, Belicchi M, Bresolin N, Porretti L, Torrente Y.

BMC Musculoskelet Disord. 2010 Jul 11;11:157. doi: 10.1186/1471-2474-11-157.

14.

Amelioration of muscular dystrophy by transgenic expression of Niemann-Pick C1.

Steen MS, Adams ME, Tesch Y, Froehner SC.

Mol Biol Cell. 2009 Jan;20(1):146-52. doi: 10.1091/mbc.E08-08-0811. Epub 2008 Oct 22.

15.

Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.

Kesari A, Fukuda M, Knoblach S, Bashir R, Nader GA, Rao D, Nagaraju K, Hoffman EP.

Am J Pathol. 2008 Nov;173(5):1476-87. doi: 10.2353/ajpath.2008.080098. Epub 2008 Oct 2.

16.

Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.

Nagaraju K, Rawat R, Veszelovszky E, Thapliyal R, Kesari A, Sparks S, Raben N, Plotz P, Hoffman EP.

Am J Pathol. 2008 Mar;172(3):774-85. doi: 10.2353/ajpath.2008.070327. Epub 2008 Feb 14.

Items per page

Supplemental Content

Write to the Help Desk